Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; Raises Target Price to $4.50
November 06, 2012 09:15 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Nov 6, 2012) - Vista Partners announced today that it has updated coverage on ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) ("ADVENTRX" or "ANX"); and raised its...